Skip to content
DraconiticResearch
Search Sources API
210,423 studies31 sourcesUpdated 57 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. A Contemporary Review of Resectability and Treatment Strategies for Colorectal Liver Metastases: Part 1—Diagnosis, Defining Resectability, and Management of Upfront Resectable and Synchronous Disease
    Jennifer A. Kalil, René Adam, Nicholas Meti +1
    CancersPeer-reviewedCC BYFull text1 citedOncologyEurope PMCCrossref
  2. MVB Maturation Responsive to KRASG12D/TP53R175H Co‐mutations Fuels Extracellular Vesicle‐hypersecretion Phenotype to Aggravate Lymphangiogenesis and Lymphatic Metastasis
    Jiabin Yang, Yuming Luo, Yu Zhou +14
    Journal of extracellular vesiclesPeer-reviewedCC BY-NCFull textOncologyEurope PMCDOAJ
  3. Differences in Somatic Mutations Between Early-Onset and Late-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis
    Hui Lionel Raphael Chen, Jun Yan Ian Wee, Jun Kiat Thaddaeus Tan +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. Contemporary Clinical Outcomes and Healthcare Utilization in Older Adults with Acute Myeloid Leukemia: Insights from a Single-Center Retrospective Cohort
    Tina Y. Zhang, Alex Y. Ge, Shyam A. Patel +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  5. Gleason Pattern 4 Burden and Adverse Pathology in ISUP Grade Group 2 Prostate Cancer: Implications for Active Surveillance Selection
    Lucas Regis, Clara Perez, Jacques Planas +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  6. Pre-Resection Endoscopic Features in T1 Colorectal Cancer Selected for Salvage Surgery After ESD/EID: An Exploratory Comparison of SM1 and SM2–3 Invasion
    Kasper Maryńczak, Julia Adamkiewicz, Jacek Kabziński +6
    Journal of clinical medicinePeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  7. Prediction of Response to Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
    Mariana Verdelho Machado
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  8. The Dynamic Role of Liquid Biopsy in Patients with Non-Small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors: Emerging Opportunities and Clinical Challenges
    Tancredi Didier Bazan Russo, Valerio Gristina, Francesco Pepe +13
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  9. Dynamic Immune Responsiveness in Breast Cancer: Tumor Microenvironment Plasticity, Therapeutic Timing, and Clinical Translation
    S. M. Nashir Udden, Monira Obaid, Laurentiu M. Pop +1
    International journal of molecular sciencesPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  10. Durvalumab Plus High-Dose Radiation in NSCLC III: Long-Term Results from the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)
    Katharina Hörmandinger, Elvis Ruznic, Marisa Klebermass +9
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  11. Changes in the Age Distribution of Radical Prostatectomy and Radical Cystectomy During the Diffusion of Robot‐Assisted Surgery in Japan
    Taku Mochizuki, Takashi Kawahara, Akihito Hashizume +5
    Cancer medicinePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCDOAJ
  12. Targeting SERPINB5 and MSLN for Pancreatic Cancer Therapy
    Jinghui Sun, Lingling Liu, Rhyston Broadhurst +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  13. The Effects of Physical and Mind–Body Exercise on Anxiety Among Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Controlled Trials
    Mesut Süleymanoğulları, Cemre Didem Eyipınar, Zarife Pancar +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  14. CABOPRE: Evaluating Perioperative Cabozantinib’s Efficacy and Biomarkers for Cytoreductive Nephrectomy in Advanced Renal Cell Carcinoma
    Guillermo de Velasco, Teresa Alonso-Gordoa, Juan Francisco Rodríguez-Moreno +16
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  15. Prognostic Markers in Triple-Negative Breast Cancer (TNBC)
    Ishaan Shah, Srushti Naik, Frank Arfuso +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  16. Uncovering the Role of Small and Intermediate-Length Non-Coding RNAs in Glioma Pathogenesis and Prognosis
    Jasmine Machhi, Priya Kumthekar, Stella Hartmann
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  17. Hexokinase II as a Potential Target of Apigenin Through the Induction of Apoptosis and Necroptosis in Malignant Mesothelioma
    Moon-Kyun Cho, Sang-Han Lee, Hae-Seon Nam +1
    NutrientsPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  18. Understanding Genomic Instability Score in Platinum-Treated Advanced Pancreatic Ductal Adenocarcinoma
    Justus Leinhos, Theodora Malli, Anna Gabler +14
    Journal of clinical medicinePeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  19. Immunohistochemistry vs Molecular Breast Cancer Subtyping Among African Populations
    Shahin Sayed, Li Feng, Hela Koka +21
    JAMA network openPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCCrossref
  20. Deep Learning on Histopathological Images Enables Accurate Diagnosis of Common B-Cell and Hodgkin Lymphoma
    Peisen Zhang, Changjiang Yan, Meilin Sun +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  21. Primary Bone Vascular Neoplasms: An Integrated Biological Perspective from Bone Pathology to Precision Oncology
    Aikaterini Anetaki, Constantine Anetakis, Ioannis Chaniotakis +4
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  22. Immune-mediated Myocarditis after Durvalumab/tremelimumab Treatment for Unresectable Hepatocellular Carcinoma
    Shogo Mawatari, Ryu Sasaki, Yasuhiko Nakao +4
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  23. Allostatic load, genetic susceptibility, and lung cancer risk: Evidence from a prospective cohort and integrative proteomic analyses
    Fan Yang, Wei Wang, Fangyi Chen +11
    PLOS Digital HealthPeer-reviewedCC BYFull textOncologyPLOSEurope PMC
  24. Modelling the efficacy of CAR-CIK cell immunotherapy targeting MET-expressing mesothelioma cells
    Federica Padovano, Andrea Maria Lombardi, Silvia Novello +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  25. Repeatability of upper limb volume measurements based on the Kuhnke measurement protocol and frustum volume calculation in women after unilateral mastectomy: a cross-sectional methodological study
    Małgorzata Smoter, Robert Roczniok, Jarosław Muracki +3
    Scientific ReportsPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ